A first-in-human phase 1 clinical study in healthy volunteers to assess the safety, tolerability and pharmacokinetics of EDI048, a novel promising agent to treat enteric cryptosporidiosis. (academic.oup.com)

Authors: Jain M … Stuart BD Journal: Journal of Infectious Diseases Published: 2026-04-10 DOI: https://doi.org/10.1093/infdis/jiag210